Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer

Mise à jour : Il y a 4 ans
Référence : NCT00049998

Femme et Homme

Extrait

The purpose of this study is to collect information on how effective and how well tolerated an oral investigational drug is compared to a standard intravenous drug in patients with pretreated, advanced non-small lung cancer (NSCLC).


Critère d'inclusion

  • non-small cell lung cancer


Liens